Agglutination immunoassay for hapten involving monoclonal antibo

Chemistry: analytical and immunological testing – Involving iga – igd – ige – or igm

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

43524027, 436509, 436533, 436534, 436548, 436808, 436821, 436825, 935103, 935110, G01N 33546, G01N 33577

Patent

active

047910674

ABSTRACT:
An assay method and kit for a hapten such as theophylline employs a first, latex reagent and a second, antibody reagent. By using a monoclonal antibody of the IgA class in the second reagent, interference by patient rheumatoid factor is prevented.

REFERENCES:
patent: 4362531 (1982-12-01), de Steenwinkel et al.
patent: 4397960 (1983-08-01), Moussebois et al.
patent: 4427781 (1984-01-01), Masson et al.
patent: 4491632 (1985-01-01), Wands
patent: 4582810 (1986-04-01), Rosenstein
patent: 4645748 (1987-02-01), Hurwitz
patent: 4659659 (1987-04-01), Dwek
M. Zrein et al., "Quantitation of Rheumatoid Factors," J. Immun. Methods, vol. 87, pp. 229-237 (1986).
L. A. Borque et al., "Immunoassay of Rheumatoid Factor by Latex Particle Counting," Clin. Chem., vol. 33, No. 5, pp. 704-707 (1987).
Opheim et al., "Particle-Enhanced Turbidimetric Inhibition Immunoassay for Theophylline Evaluated with the DuPont aca", Clin. Chem. vol. 30, No. 11, pp. 1870-74 (1984).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Agglutination immunoassay for hapten involving monoclonal antibo does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agglutination immunoassay for hapten involving monoclonal antibo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agglutination immunoassay for hapten involving monoclonal antibo will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2195956

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.